Annual Revenue
$2.46 B
+$1.04 B+73.65%
31 December 2023
Summary:
BeiGene annual revenue is currently $2.46 billion, with the most recent change of +$1.04 billion (+73.65%) on 31 December 2023. During the last 3 years, it has risen by +$1.28 billion (+109.03%). BGNE annual revenue is now at all-time high.BGNE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.00 B
+$72.43 M+7.80%
30 September 2024
Summary:
BeiGene quarterly revenue is currently $1.00 billion, with the most recent change of +$72.43 million (+7.80%) on 30 September 2024. Over the past year, it has increased by +$367.19 million (+57.88%). BGNE quarterly revenue is now at all-time high.BGNE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$3.32 B
+$220.29 M+7.11%
30 September 2024
Summary:
BeiGene TTM revenue is currently $3.32 billion, with the most recent change of +$220.29 million (+7.11%) on 30 September 2024. Over the past year, it has increased by +$858.05 million (+34.90%). BGNE TTM revenue is now at all-time high.BGNE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGNE Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +57.9% | +34.9% |
| 3 y3 years | +109.0% | +368.1% | +182.0% |
| 5 y5 years | +474.2% | +1660.5% | +674.6% |
BGNE Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +109.0% | at high | +368.1% | at high | +278.2% |
| 5 y | 5 years | at high | +696.0% | at high | +1824.0% | at high | +1375.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
BeiGene Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.00 B(+7.8%) | $3.32 B(+7.1%) |
| June 2024 | - | $929.17 M(+23.6%) | $3.10 B(+12.1%) |
| Mar 2024 | - | $751.65 M(+18.5%) | $2.76 B(+12.4%) |
| Dec 2023 | $2.46 B(+73.7%) | $634.41 M(-18.8%) | $2.46 B(+11.5%) |
| Sept 2023 | - | $781.31 M(+31.3%) | $2.20 B(+21.7%) |
| June 2023 | - | $595.26 M(+32.9%) | $1.81 B(+16.3%) |
| Mar 2023 | - | $447.80 M(+17.8%) | $1.56 B(+10.0%) |
| Dec 2022 | $1.42 B(+20.4%) | $380.10 M(-1.9%) | $1.42 B(+13.3%) |
| Sept 2022 | - | $387.63 M(+13.5%) | $1.25 B(+17.0%) |
| June 2022 | - | $341.57 M(+11.4%) | $1.07 B(+21.8%) |
| Mar 2022 | - | $306.63 M(+43.3%) | $877.04 M(-25.4%) |
| Dec 2021 | $1.18 B(+280.8%) | $213.98 M(+3.7%) | $1.18 B(+10.7%) |
| Sept 2021 | - | $206.44 M(+37.6%) | $1.06 B(+12.2%) |
| June 2021 | - | $149.99 M(-75.2%) | $947.04 M(+9.8%) |
| Mar 2021 | - | $605.87 M(+505.3%) | $862.69 M(+179.3%) |
| Dec 2020 | $308.87 M(-27.9%) | $100.10 M(+9.9%) | $308.87 M(+16.3%) |
| Sept 2020 | - | $91.08 M(+38.8%) | $265.67 M(+18.2%) |
| June 2020 | - | $65.64 M(+26.1%) | $224.73 M(-44.2%) |
| Mar 2020 | - | $52.06 M(-8.5%) | $402.44 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $428.21 M(+116.0%) | $56.89 M(+13.5%) | $428.21 M(-0.4%) |
| Sept 2019 | - | $50.14 M(-79.4%) | $429.99 M(-0.9%) |
| June 2019 | - | $243.35 M(+212.7%) | $434.05 M(+78.2%) |
| Mar 2019 | - | $77.83 M(+32.7%) | $243.51 M(+22.8%) |
| Dec 2018 | $198.22 M(-16.8%) | $58.67 M(+8.2%) | $198.22 M(+25.7%) |
| Sept 2018 | - | $54.20 M(+2.6%) | $157.72 M(-51.3%) |
| June 2018 | - | $52.80 M(+62.3%) | $323.74 M(+19.5%) |
| Mar 2018 | - | $32.54 M(+79.1%) | $270.93 M(+13.7%) |
| Dec 2017 | $238.39 M(>+9900.0%) | $18.17 M(-91.7%) | $238.39 M(+8.3%) |
| Sept 2017 | - | $220.21 M(>+9900.0%) | $220.21 M(+2989.8%) |
| Dec 2016 | $1.07 M(-87.9%) | - | - |
| June 2016 | - | $393.00 K(-41.9%) | $7.13 M(-12.2%) |
| Mar 2016 | - | $677.00 K(-85.5%) | $8.11 M(-8.0%) |
| Dec 2015 | $8.82 M(-32.4%) | $4.68 M(+238.9%) | $8.82 M(+59.7%) |
| Sept 2015 | - | $1.38 M(0.0%) | $5.52 M(-48.1%) |
| June 2015 | - | $1.38 M(+0.1%) | $10.64 M(+14.9%) |
| Mar 2015 | - | $1.38 M(-0.1%) | $9.26 M(+17.5%) |
| Dec 2014 | $13.04 M(+16.9%) | $1.38 M(-78.7%) | $7.88 M(+21.3%) |
| Sept 2014 | - | $6.50 M | $6.50 M |
| Dec 2013 | $11.15 M | - | - |
FAQ
- What is BeiGene annual revenue?
- What is the all time high annual revenue for BeiGene?
- What is BeiGene quarterly revenue?
- What is the all time high quarterly revenue for BeiGene?
- What is BeiGene quarterly revenue year-on-year change?
- What is BeiGene TTM revenue?
- What is the all time high TTM revenue for BeiGene?
- What is BeiGene TTM revenue year-on-year change?
What is BeiGene annual revenue?
The current annual revenue of BGNE is $2.46 B
What is the all time high annual revenue for BeiGene?
BeiGene all-time high annual revenue is $2.46 B
What is BeiGene quarterly revenue?
The current quarterly revenue of BGNE is $1.00 B
What is the all time high quarterly revenue for BeiGene?
BeiGene all-time high quarterly revenue is $1.00 B
What is BeiGene quarterly revenue year-on-year change?
Over the past year, BGNE quarterly revenue has changed by +$367.19 M (+57.88%)
What is BeiGene TTM revenue?
The current TTM revenue of BGNE is $3.32 B
What is the all time high TTM revenue for BeiGene?
BeiGene all-time high TTM revenue is $3.32 B
What is BeiGene TTM revenue year-on-year change?
Over the past year, BGNE TTM revenue has changed by +$858.05 M (+34.90%)